Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, Caliper Strike Co-Marketing Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences and Illumina will co-market Caliper's library sample preparation and analysis and quality control tools with Illumina's genome sequencing platforms, Caliper said today.

Caliper said the firms have signed an agreement covering marketing for its LabChip XT library preparation tool and its LabChip GX quality control platform for use with Illumina's Genome Analyzer and HiSeq2000 systems.

The LabChip XT is used to replace gel isolation steps in the sequencing library prep process, and the GX uses microfluidics technology to perform electrophoretic separations for analyzing DNA or RNA size, concentration, or integrity.

"The LabChip XT in particular was developed with direct input from Illumina and we are excited to enter into this co-marketing agreement to promote both LabChip products to address critical bottlenecks in sample preparation of next-generation sequencing libraries," Caliper CEO and President Kevin Hrusovsky said in a statement.